Jakarta, August 23, 2019 - PT Kalbe Farma Tbk (Kalbe) today through one of its subsidiaries, PT Bifarma Adiluhung, that produces the genetic testing product, Nutrigen-me; launched four new panels: hormones, methylation, inflammation and antioxidants, plus sleep and lifestyle. The launch of this panel was marked by a health discussion with the theme “Preventing Cardiometabolic Disease and Obesity with Gene Diet”; with speakers Dr.Win Johanes MS, SpGK, Chair of the Indonesian Clinical Nutrition Specialist Association Association Jakarta Branch; dr. Bibiana Bailo, Nutrigenomics Expert from the University of Toronto Canada; and Julito P. Siahaan, Head of Genomic Business of PT Bifarma Adiluhung.

Jakarta, July 31, 2019 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced net sales of Rp 11,179 billion for the first semester of 2019, an increase of 7.7% compared to the same period last year of Rp 10,381 billion.